Merck Life Science
Together, we impact life and health with science. We are the life science business of Merck. That’s where we come in. Not intended for US & CA visitors.
Together with our colleagues, customers and stakeholders, we impact life and health with science. Before researchers can make scientific breakthroughs, they must have access to state-of-the-art tools, services and expertise to perform experiments and engineer new products. We offer one of the broadest portfolios in the industry for scientists, best-in-class products for pharmaceutical development
06/12/2023
Bayesian Back End (BayBE) brings experimental planning to the digital benchtop with an AI-based toolbox capable of designing smart experimental campaigns. Scientists can optimize conditions, run simulations, explore formulations, and more, reducing the time and cost of experimental screening efforts. The tool is now available open source on GitHub.
Learn more:
Merck KGaA, Darmstadt, Germany, Collaborates with Acceleration Consortium on Open-Sourcing AI-Driven Experimentation Planner AI-driven experimentation planner BayBE (Bayesian Back End) by us and Acceleration Consortium is available open-source on GitHub
05/12/2023
We’re elevating drug discovery with the power of AI! We just unveiled AIDDISON, a generative AI, machine learning, and computer-aided design platform that explores a universe of >60 billion compounds to generate novel drug candidates. When paired with SYNTHIA, our retrosynthesis software, scientists can easily identify potential drug candidates and develop optimized synthesis pathways.
Learn more:
Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis Combines generative AI, machine learning and computer-aided drug-design to increase the success rate of new drugs and therapies
01/12/2023
For International Day of Persons with Disabilities, we are shining a light on some of our amazing colleagues in Brazil who are finding new ways to create an even more inclusive workplace.
Meet Glauce Pardine and Anderson Falcoeiras from Merck Healthcare KGaA. They noticed an opportunity to strengthen the connection between employees with and without hearing ability at their manufacturing site. Their solution? Teach the Brazilian sign language, or Libras, to employees who did not already sign to create an even more inclusive and safe environment for all employees. Starting small with ‘good morning’ and increasing the teams’ vocabulary from there, colleagues are now having full conversations in Libras.
Miguel Carvalho hosts [Coffee with LIBRAS] or [Café com LIBRAS] every month, bringing together two employees, one with and one without hearing ability. Over a cup of coffee, they connect, learn, and bond using Libras.
"Diversity makes a better group," says Glauce, urging everyone to be emphatic and open-minded so that we can all be part of the solution.
We had no idea our filters could be used to do this...🦈 Read the full story: http://ms.spr.ly/6184iMmJ4
From the first drop of lab water from a Milli-Q system 50 years ago to today, we’ve steadily innovated our solutions, remaining on the cutting edge of lab water 💦💪
28/11/2023
We are excited to announce the latest addition to our global M Lab Collaboration Center network with our latest opening in Taiwan! As one of the first technical service labs in Taiwan, it will join our global network of 300+ M Lab Collaboration Center experts, serving as a hub empowering drug developers and driving innovation in the region.
The new lab will also continue the legacy of training and nurturing top talents in the biopharma industry, working with the National Taiwan University and the Industrial Technology Research Institute, with which we have collaborated since 2018.
Kudos to the incredible team for achieving this historic milestone!
Navigating the intricate landscape of mRNA therapeutic development is no small feat. From the challenges of formulating suitable lipid nanoparticles to storing them at the right temperature, the journey demands precision at every step.
We're confident those challenges can be overcome with expertise and innovation, so our clients can focus on what they do best: helping patients. Eleni explains how.
24/11/2023
Why are our scientists discussing a space shuttle with an astronaut?
It has little to do with aeronautical engineering but everything to do with potentially curing incurable diseases like cancer:
The Science Behind mRNA and Delivery Shuttles There's more (science) behind the word “mRNA” — from custom lipids to specialized manufacturing processes.
We've put our new Ultimus Film to the test - in more ways than one!
We developed the new film to help prevent significant pain point in single-use biomanufacturing: bag failures. To get there, we put the Ultimus Film through test after test to ensure it was stronger and more leak-resistant for the most challenging single-use bioprocessing liquid applications.
Take an inside look at how we came up with this innovation here: http://ms.spr.ly/6187iHXFL
22/11/2023
See this change? This switch saved 23 metric tons of expanded polystyrene (EPS) annually. AND it's just one of the many packaging projects helping us reach our 2030 goal to align 100% of new product packaging with our packaging sustainability principles.
21/11/2023
We've expanded our Biologics Testing Center in Shanghai, China! The €29 million, 1,500 square meter addition means customers have even greater access to our broad range of testing services. This includes cell line characterization which helps ensure the safety, purity, and identity of cell banks.
With the completion of phase two of the facility, we now offer a broad range of biosafety testing services for monoclonal antibodies, other recombinant proteins, and cell and gene therapies in China.
Learn more about this milestone here:
Dr. Spuler at Max Delbruck Center is at the forefront of tackling genetic and acquired muscle diseases, and she's making breakthroughs. That dedication to helping patients with few or even no treatment options led her team to Merck and our mRNA Center of Excellence in Hamburg.
As the world's first integrated provider of mRNA services, we believe in the power of mRNA technology and its curative potential for diseases previously thought to be incurable, including diseases Dr. Spuler has dedicated her life to. Watch to hear her story.
It’s been 50 years since we launched our first Milli-Q Lab Water System. Along the way, we’ve taken many steps—big & small—to make our solutions more sustainable. Check out how today’s solutions are creating a greener tomorrow.
For more information, visit: http://ms.spr.ly/6184i84AY
14/11/2023
We’re proudly introducing ChemisTwin, a first-of-its-kind digital reference material platform for analytical testing. Certified reference materials play a crucial role in ensuring the accuracy, reliability, and comparability of measurements and analyses in the life science industry. This platform offers traceable digital records of physical reference materials, allowing Pharma QC/QA and R&D to increase the sampling rate and identify sample inconsistencies to ensure safer products.
Learn more:
Merck Launches ChemisTwin™, First Ever Digital Reference Materials Platform for Analytical Testing Merck has launched ChemisTwin™, the first digital reference materials platform that can perform automatic analysis of samples’ purity, identification, and degradation of compounds through calibrated algorithm-based digital references.
Honk, honk! Science on wheels? 🚐
Our team in Europe is bringing cutting-edge science directly to our customers' front steps... in a van! They're showcasing our biopharmaceutical production capabilities in a unique and accessible setting.
See how they're hitting the road, offering demos and consultations while engaging with customers to help them impact even more lives with science.
From the next big breakthrough in medicine to the innovations of our wildest dreams, we look to science to improve our world. On , we celebrate the science of today and its innovators of tomorrow. At our Curiosity Cube mobile science lab, we asked those future scientists why science is so important, and their answers didn't disappoint. Happy World Science Day!
08/11/2023
We just signed a Memorandum of Understanding with Daewoong Pharmaceutical to support their AI-driven drug development work.
Our collaboration aims to enhance the process of identifying optimal routes for drug manufacturing, notably using our retrosynthesis software SYNTHIA, paving the way for groundbreaking advancements in the industry. Learn more: http://ms.spr.ly/61849CyLs
Congratulations Ji Young Chung, Minsoo Kang, and the entire team!
1,700 participants. 400 companies. 5 years of collaborations. 🎉 We just celebrated our M Lab Collaboration Center's 5th anniversary in Brazil! Since opening, the center has become the go-to place to explore ideas, learn innovative techniques, and collaborate with our experts in Brazil.
Congratulations to the entire team!
Excited students and employee volunteers joined us for three days of tiny robots and crazy microbes at the Science Days event at Europa Park in Germany. With over 3,700 curious young minds in attendance, there were plenty of smiles, questions, and so much scientific exploration. Check out the highlights below🔬🎊
03/11/2023
🥳 🎉 Popping up in your Friday feed to celebrate some exciting news: we won the Sustainability Leaders | A World 50 Group Community's “Sustainability Excellence” award, the largest category award!
We were awarded for the impact of our vision and strategy in product design, increasing renewable energy, and supporting under-resourced students & communities through our SPARK program. Let’s keep the momentum going! 🥳💪
02/11/2023
Today, Merck Group announced the signing of virtual power purchase agreements in Spain, which are expected to produce 300 gigawatt hours of electricity annually through a mix of solar and wind power. This is a testament to our ambitious sustainability strategy, underpinning our commitment to a more sustainable future.
Once operational at the end of 2025, these VPPAs will boost our Life Science business from 77% to 90% renewable electricity globally. Plus, check this out: We're already matching 100% of our operation's electricity with renewable energy in the U.S., Switzerland, Argentina, Guatemala, Chile, and Brazil!
All these developments put us on track to reach our larger goal of climate neutrality by 2040 🌏
Learn more here: http://ms.spr.ly/618794bmJ
VPPAs for Europe | Merck KGaA, Darmstadt, Germany Company has signed virtual power purchase agreements (VPPAs) for a total of around 300 gigawatt hours (GWh) of renewable energy per year.
01/11/2023
Not everyone time travels on the job, but Paula does. Read her story here:
Meet Dr. Paula Shively Dr. Paula Shively, a longtime technical service expert, guides scientists through challenging moments in the lab. A decade later, she vividly remembers one conversation.
👻 Boo to all you geeks and ghouls. Is our 3D bioprinter haunted, or are our scientists having too much fun? Watch the video to find out.
Interested in learning more about 3D bioprinting? Visit: http://ms.spr.ly/6180924kK
Your phone goes with you everywhere. It’s your connection to friends, your to-do list, the soundtrack to your workout, and more. Find out which microbes it collects along the way.
27/10/2023
In October, we celebrated the 5th anniversary of the M Lab Collaboration Center in Brazil in the best way possible: by inviting employee volunteers, members of the community, and almost 30 local school children to join an onsite SPARK event. During the event, they explored the M Lab and learned about filtration, pH, and DNA through hands-on experimentation.
From these pictures, we can tell they had a great time. By the way, do you remember what first sparked your scientific curiosity?
We don’t know about you, but we’re excited to try cultured meat 🥩 Tim Olsen, cultured meat expert, shares how it is made in the video below.
mRNA may have been thrown into the limelight during the last pandemic, but its research spans over 60 years. Its unparalleled versatility promises what no other modality can: treating everything from genetic disorders like muscular dystrophy and cancer to viruses like SARS-CoV-2.
Meet Eleni, who is committed to turning the versatility of mRNA technology into a viable treatment for patients.
Interested in learning more? Read her full story here: http://ms.spr.ly/61829LKde
A tiny device with a big impact.
The organ-on-a-chip technologies use microfluidics to mimic the microarchitecture and functions of living organs, which could revolutionize the drug clinical testing. Curious? Learn more here: http://ms.spr.ly/61829xVdq
20/10/2023
Ready to dive into the future of biotech?
Don't miss out on our Emerging Biotalk Blog, your one-stop source for the latest biotechnology trends and cutting-edge drug development tech. Check it out here:
Home - Emerging BioTalk This is a Page excerpt. It will be displayed for search results
🤔 We asked non-chemist colleagues if they could describe what this glassware was used for. Watch to see if they got it right.
We just celebrated the 5th anniversary of our M Lab Collaboration Center and the BioReliance Biosafety Testing Lab in Singapore!
It's been an amazing journey of innovation and collaboration, and we've only just begun! We look forward to continuing our work with customers to further their impact on life and health for years to come. Congratulations team!
**Adds to purchase list: 1 Snow cone machine ❄️ ✅
It's mission possible with Amie Muir! Tag along as one of our molecular biologists at our testing facility in Glasgow takes on a new mission: testing medicine for viral contaminants to ensure they are safe.
12/10/2023
One treatment to cure them all?
The flexibility and versatility of mRNA technology can potentially cure influenza, malaria, and even cancer. Find out how our scientists are working together to propel the promise of mRNA here: http://ms.spr.ly/61869tKuA
The Science Behind mRNA and Delivery Shuttles There's more (science) behind the word “mRNA” — from custom lipids to specialized manufacturing processes.
Did you know? We've been a key player in the world of mRNA research since the 1990s, providing critical components and raw materials to unlock the curative potential of mRNA.
A versatile toolkit with endless possibilities, as our scientist Aditi describes; hear how she and her team of scientists are trying to make mRNA therapeutics accessible for patients worldwide.
Still curious? Read her full story here http://ms.spr.ly/61839sckR
Cultured meat has been in the news recently. Find out what challenges manufacturers must overcome before we see these products in our supermarkets.
Colorful pills are not just for looks! 💊
Color-coated tablets can indicate different therapeutic strengths, help prevent patient mix-ups, and more.
Discover how our Parteck TA coating can help enhance drug tablets with Thomas.
06/10/2023
We are thrilled to share our latest ‘roaring’ achievement in Singapore, welcoming the new Life Science distribution center with a symbolic lion dance performance. The traditional lion dance symbolizes good luck and prosperity.
This distribution center will help us further support our customers in Singapore and across Asia Pacific as they work to advance science.
Congratulations to the team!
02/10/2023
Congratulations to the winning Team of the 4th Compound Challenge, Team UGOT! 👏 Want to join the winner's circle?
Enter to win the 5th Compound Challenge, a worldwide retrosynthesis competition to design the best synthetic route for a target molecule.
Sign up now for a chance to win a prize of 10,000 EUR.
Compound Challenge Scientists are invited to provide an original synthesis protocol for a small molecule.
mRNA promises to revolutionize how we treat and possibly cure a wide range of diseases, from cancer to heart disease and muscular dystrophy. The possibilities may be endless. That's why we continue to invest in advancing mRNA technologies.
As the first CTDMO (contract testing, development, and manufacturing organization) to offer integrated services for all critical mRNA development, manufacturing, and commercialization stages, we're working alongside customers at every stage of the process. Our integrated approach encompasses analytical development, biosafety testing tailored for mRNA technologies, and a streamlined process accelerating our clients’ speed-to-market.
We’re making bold strides and propelling the curative promise of mRNA hand in hand with our customers.
Our Story
The life science business of Merck serves more than 1.5 million global customers – academia, biotech and pharma – helping them to deliver the promise of their work better, faster and safer. As a leading player in the attractive life science industry, we offer innovative solutions for scientists and engineers at every stage.
Our purpose is to solve the toughest problems in life science by collaborating with the global scientific community – and through that, we aim to accelerate access to health for people everywhere. Udit Batra has been the CEO of Life Science since 2014 and a member of the Merck Executive Board since 2016.
With the 2015 combination of Merck Millipore and Sigma-Aldrich, we now have a broad portfolio of 300,000 products, an expanded global footprint and an industry-leading eCommerce platform - SigmaAldrich.com.
Videos (show all)
